OCTAGAM

I appreciate your request, but

I need to clarify an important issue with the source documents provided.

The documents contain information about two different medicines:

1. **Document 1** describes Zoster Immunoglobulin-VF (human zoster immunoglobulin for intramuscular injection) – a product for varicella prophylaxis, sponsored by CSL Behring, with initial ARTG approval dated 07 April 2005.

2. **Document 2** lists ARTG entries for OCTAGAM, which is normal immunoglobulin (human) for intravenous infusion and injection, sponsored by Octapharma, first listed from 2004 onwards.

These are distinctly different medicines with different compositions, routes of administration, indications, and sponsors.

**The user has requested a Brand Dossier for OCTAGAM (Octapharma's normal immunoglobulin product), but Document 1 describes an entirely different product (Zoster Immunoglobulin-VF by CSL Behring).**

Document 2 provides only ARTG registration details for OCTAGAM but lacks clinical information needed for a comprehensive Brand Dossier (approved indications, dosing, safety warnings, contraindications, PBS listing, and detailed regulatory history).

To write an accurate Brand Dossier for OCTAGAM as specified, I would need a product information document or equivalent source that covers OCTAGAM's clinical particulars, dosing, contraindications, and safety information.

Could you please provide the appropriate source document for OCTAGAM, or clarify whether the dossier should be for Zoster Immunoglobulin-VF instead?